Dr. Diamond previously held several senior-level positions at Bayer Diagnostics. From 2000-2004, he was vice president research and development for the near-patient-testing segment. Before that, he was vice president, research and development for the self-testing segment. Prior to joining Bayer, he was vice president, research and development for the Stratus Immunochemistry business of Baxter Diagnostics. Dr. Diamond received a bachelor's degree cum laude in chemistry from Rensselaer Polytechnic Institute (Troy, New York) and a PhD in chemistry from Stanford University (Stanford, California), with Nobel Laureate, Professor Henry Taube, as his research advisor. He is the recipient of several honors and awards, has authored many technical publications and abstracts in peer-reviewed journals, and is the co- holder of numerous United States and international patents.
About Magellan Biosciences
Magellan serves the worldwide clinical-diagnostics market with rapid
point-of-care analyzers and automated systems for hospital-based labs and
near-patient testing. Scientists use the company's discovery systems and
sensors for cutting-edge research to develop a new understanding of health
and illness -- from disease pathology to biomarker identification. Magellan
designs all its systems, sensors, and consumables to deliver better, more-
reliable results. And bett
|SOURCE Magellan Biosciences|
Copyright©2007 PR Newswire.
All rights reserved